U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493031) titled 'A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HW252001 in Healthy Subjects' on March 20.
Brief Summary: This is a phase 1, randomized, double-blind, placebo-controlled, Single/multiple ascending doses (SAD/MAD) study of HW252001 in healthy subjects. This study aims to evaluate the safety, tolerability, pharmacokinetics and Pharmacodynamics of HW252001.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
IPF
Intervention:
DRUG: HW252001
HW252001 will be administered as oral tablets at assigned dose levels within each cohort in Part 1 (SAD) and Part 2 (MAD).
DRUG: Plac...